maxcyte.com - MXCT Company Short-Term Debt

MaxCyte Inc. (MXCT) - corporate logo

MaxCyte, Inc. (MXCT) operates as a B2B provider of cell modification tools, scaling its operations by expanding its network of contracts with pharmaceutical behemoths. The business relies on the sale of specialized electroporation systems in high demand among gene therapy developers. The current metric stands at 0.00. This daily price chart below illustrates the market quotes for this manufacturer of high-precision biomedical research equipment.

MXCT: MaxCyte Short-Term Debt 07/04/2022 - 10/28/2026

Summary analytical data breakdowns for MaxCyte Inc (MXCT)

- price and consensus price forecast:
Stock Price MaxCyte|MXCT - Analyst Target Range
- market capitalization data:
Market Value MaxCyte, Inc.|MXCT - Business Value
- book capitalization data:
Net Assets per Single Share MaxCyte|MXCT - Total Stockholders' Equity|Market Value to Book Value Ratio maxcyte.com|MXCT - Company Total Asset Base
- debt and liquidity data:
Total Debt to Equity Ratio MaxCyte, Inc.|MXCT - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital MaxCyte, Inc.|MXCT - Company Total Debt Obligations|Debts to Book Capitalization MaxCyte, Inc.|MXCT - Company Long-Term Liabilities|Company Current Liabilities MaxCyte
Analysis of all company metrics:MaxCyte - MXCT
Original product of MaxCyte Inc

Short-term debt measures the volume of borrowing obligations with a maturity of up to one year, determining current liquidity. An increase in this metric signals a risk of cash flow gaps and pressure on working capital. By analyzing short-term financial debt, an investor assesses the company's ability to service operational loans. For MaxCyte, Inc. (MXCT), debt control is critical when scaling energy-efficient cell engineering technologies. This ensures the sustainable development of environmental innovations in laboratory equipment.

Competitor analysis

Company Short-Term Debts ABT|TMO: Short-Term Indebtedness|Company Short-Term Debt GE Healthcare Corp|MTD (Mettler Toledo Inc) - Company Short-Term Indebtedness|Company Short-Term Debt WAT (Waters Corporation)|Short-Term Debt TECH|BRKR (Bruker) - Company Short-Term Debt|Short-Term Debt Volume Azenta Inc AZTA|Company Current Liabilities Varex (VREX)|Amount of Current Liabilities Semler SMLR|Company Short-Term Debts BFLY (Butterfly Network, Inc.)|MLAB - Short-Term Debt Volume|QSI (Quantum-Si Incorporated) - Company Short-Term Debts|Company Current Liabilities Nano-X Imaging|QTRX - Company Current Liabilities|Company Short-Term Loans and Borrowings MASS|Company Short-Term Debt CV (CapsoVision Inc)|Company Current Liabilities rapidmicrobio.com (RPID)|SEER: Company Short-Term Debts|Short-Term Debt Hyperfine Inc HYPR|FONAR Corp (FONR) - Company Short-Term Debts|DXR - Company Short-Term Indebtedness|Spectral AI, Inc. - Company Short-Term Debts|Organovo (VIVS) - Short-Term Debt Volume|Company Short-Term Debts ACON|Company Current Liabilities Akoya|Company Short-Term Debts THMO|Company Short-Term Debts TLIS (talis.bio)|Company Short-Term Debt T2 Biosystems, Inc. TTOO